TrialFrontiers in immunology2025

Prognostic value of patient-reported outcomes for survival in patients with advanced lung cancer receiving immune checkpoint inhibitors.

David Gandara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.